J.B. Chemicals & Pharmaceuticals Ltd.

₹ CrorePeersTORNTPHARM ALKEM IPCALAB SAILIFE NH NEULANDLAB ACUTAAS NATCOPHARM

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026
Non-current Assets
+ Property, Plant & Equipment	571.6	609.9	611.6
+ Capital Work-in-Progress	63.3	46.7	61.2
+ Goodwill	57.5	57.5	57.5
+ Other Intangibles	1,375.4	1,300.8	1,216.3
+ Intangibles under Development	13.1	16.4	12.8
+ Non-current Investments	23.7	28.0	26.0
+ Long-term Loans	0.6	0.4	0.2
+ Other Non-current Financial Assets	10.0	255.8	30.2
Non-current Financial Assets	34.3	284.1	56.4
+ Deferred Tax Assets	5.9	8.4	6.9
+ Other Non-current Assets	4.9	15.5	—
Total Non-current Assets	2,125.8	2,339.3	2,022.6
Current Assets
+ Inventories	502.5	529.0	683.4
+ Current Investments	364.7	317.1	738.9
+ Trade Receivables	686.9	815.4	780.9
+ Cash & Cash Equivalents	88.2	115.1	110.2
+ Other Bank Balances	7.3	14.4	35.7
+ Short-term Loans	0.7	0.6	0.5
+ Other Current Financial Assets	12.7	14.5	559.7
Current Financial Assets	1,160.5	1,277.0	2,226.0
+ Other Current Assets	190.3	116.8	182.2
Total Current Assets	1,868.3	1,934.5	2,946.0
Total Assets	3,994.1	4,273.8	4,968.7
Equity
+ Equity Share Capital	15.5	15.6	16.1
+ Other Equity / Reserves	2,907.8	3,417.8	4,143.2
Equity — Owners of Parent	2,923.3	3,433.3	4,159.2
+ Minority Interest	0.0	1.0	3.1
Total Equity	2,923.3	3,433.3	4,159.2
Liabilities
+ Borrowings — Non-current	23.6	0.0	0.0
+ Other Non-current Financial Liab	9.6	6.4	1.1
Non-current Financial Liabilities	33.3	6.4	1.1
+ Provisions — Non-current	18.4	22.5	29.4
+ Deferred Tax Liabilities	149.2	177.3	184.2
+ Other Non-current Liabilities	1.7	1.9	3.6
Non-current Liabilities	202.6	208.1	218.3
+ Borrowings — Current	333.5	13.8	0.0
+ Trade Payables	356.3	410.7	391.0
+ Other Current Financial Liab	93.4	115.0	125.7
Current Financial Liabilities	783.2	539.6	516.7
+ Provisions — Current	49.1	62.3	65.3
+ Current Tax Liabilities	11.8	8.2	9.2
+ Other Current Liabilities	24.2	22.3	33.1
Current Liabilities	868.2	632.3	591.2
Total Liabilities	1,070.8	840.5	809.4
Total Equity & Liabilities	3,994.1	4,273.8	4,968.7
Assets — additional as-filed lines
+ Current Tax Assets	15.0	11.7	36.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	37.0	51.5
+ Dues to Other Creditors — Current	—	373.7	339.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.